Crossmark

Leukocytosis in Cushing’s syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing’s disease

Crossref DOI link: https://doi.org/10.1007/s40618-025-02535-2

Published Online: 2025-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Masri-Iraqi, Hiba https://orcid.org/0000-0002-0889-8025
Rudman, Yaron https://orcid.org/0000-0003-3220-6321
Shochat, Tzipora https://orcid.org/0000-0002-7576-8327
Kushnir, Shiri https://orcid.org/0000-0003-2359-5249
Shimon, Ilan https://orcid.org/0000-0002-9188-3894
Fleseriu, Maria https://orcid.org/0000-0001-9284-6289
Akirov, Amit https://orcid.org/0000-0002-9376-344X
Funding

Funding for this research was provided by:

Tel Aviv University
License Information

Text and Data Mining valid from 2025-01-28

Version of Record valid from 2025-01-28
More Information

Article History

Received: 24 October 2024

Accepted: 10 January 2025

First Online: 28 January 2025

Declarations

:

: The authors have no conflict of interest to declare for this study.